137 related articles for article (PubMed ID: 35400251)
1. Can omega-3 fatty acids be beneficial in pediatric NAFLD? A systematic review and meta-analysis.
Dionysopoulos G; Kalopitas G; Vadarlis A; Bakaloudi DR; Gkiourtzis N; Karanika E; Tsekitsidi E; Chourdakis M
Crit Rev Food Sci Nutr; 2023; 63(27):8545-8553. PubMed ID: 35400251
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Yan JH; Guan BJ; Gao HY; Peng XE
Medicine (Baltimore); 2018 Sep; 97(37):e12271. PubMed ID: 30212963
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
Kelley NS
Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
[TBL] [Abstract][Full Text] [Related]
6. The Benefit of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: A Meta-analysis of Randomized Control Trials.
Gkiourtzis Ν; Kalopitas G; Vadarlis A; Bakaloudi DR; Dionysopoulos G; Karanika E; Tsekitsidi E; Chourdakis M
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):e31-e37. PubMed ID: 35758473
[TBL] [Abstract][Full Text] [Related]
7. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Gkiourtzis N; Michou P; Moutafi M; Glava A; Cheirakis K; Christakopoulos A; Vouksinou E; Fotoulaki M
Eur J Pediatr; 2023 Nov; 182(11):4795-4806. PubMed ID: 37639015
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials.
Chen LH; Wang YF; Xu QH; Chen SS
Clin Nutr; 2018 Apr; 37(2):516-521. PubMed ID: 28040302
[TBL] [Abstract][Full Text] [Related]
10. Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial.
Barroso LN; Salarini J; Leite NC; Villela-Nogueira CA; Dávalos A; Carmo MDGT; Ferreira Peres WA
Clin Nutr ESPEN; 2023 Oct; 57():117-125. PubMed ID: 37739645
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
Guo XF; Yang B; Tang J; Li D
Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of different treatment modalities in the management of pediatric non-alcoholic fatty liver disease: A systematic review and network meta-analysis.
Theodoridis X; Kalopitas G; Vadarlis A; Bakaloudi DR; Gkiourtzis Ν; Dionysopoulos G; Karanika E; Tsekitsidi E; Chourdakis M
Pharmacol Ther; 2022 Dec; 240():108294. PubMed ID: 36183848
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: An umbrella systematic review and meta-analysis.
Musazadeh V; Karimi A; Malekahmadi M; Ahrabi SS; Dehghan P
Clin Exp Pharmacol Physiol; 2023 May; 50(5):327-334. PubMed ID: 36692292
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis.
Shi XY; Fan SM; Shi GM; Yao J; Gao Y; Xia YG; Chen Q
Medicine (Baltimore); 2020 Jun; 99(24):e20624. PubMed ID: 32541499
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and meta-analysis of randomized controlled trials to evaluate plant-based omega-3 polyunsaturated fatty acids in nonalcoholic fatty liver disease patient biomarkers and parameters.
Moore E; Patanwala I; Jafari A; Davies IG; Kirwan RP; Newson L; Mazidi M; Lane KE
Nutr Rev; 2024 Jan; 82(2):143-165. PubMed ID: 37290426
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]